Search Results
Results found for "Martin Lohse"
- Dr. Hannes Schihada | Dr. GPCR Ecosystem
Schihada Following studies in Pharmacy in Regensburg, Germany, I joined the receptor pharmacology group of Martin Lohse at the Institute of Pharmacology & Toxicology in Würzburg, Germany, in 2015.
- Dr. Katarina Nemec | Dr. GPCR Ecosystem
During my PhD studies in Martin Lohse lab at the Max Delbrueck Center in Berlin, I consolidated my knowledge
- Martin Audet | Dr. GPCR Ecosystem
<< Back to podcast list Strategic Partner(s) Martin Audet About Dr. Martin Audet Structural biologist, pharmacologist, and a professor of pharmacology at Université de Sherbrooke Martin Audet on the web LinkedIn Twitter Sherbrooke University Google Scholar Dr.
- Dr. Jean Martin Beaulieu | Dr. GPCR Ecosystem
Jean Martin Beaulieu About Dr. Jean Martin Beaulieu Dr. Jean Martin Beaulieu on the web University of Toronto Google Scholar LinkedIn ResearchGate Dr.
- GPCR Assay Strategy, Bias, and Translational Drug Discovery | Dr. GPCR Ecosystem
Explore Martin Marro’s impact on GPCR drug discovery, assay innovation, and translational pharmacology Martin Marro, currently Executive Director and Head of Cell Pharmacology at Eli Lilly’s Obesity Research About Martin Marro Dr. Martin Marro leads the Cell Pharmacology group in the Diabetes, Obesity and Complications Therapeutic
- Dr. Thomas P. Sakmar | Dr. GPCR Ecosystem
Instructors at the course included Marc Chabre , Harden McConnell , Richard Henderson , Martin Rodbell , Jean-Pierre Changeux , and Martin Karplus .
- Dr. Caron Tribute Part 3 | Dr. GPCR Ecosystem
Jean Martin Beaulieu (2003) Dr. Laura Bohn (1999) Dr. Kathleen Caron - Co-host- (1970) Dr.
- Dr. Timo De Groof | Dr. GPCR Ecosystem
Martine Smit . During his Ph.D., Timo, together with Dr.
- Leadership, Impact, and GPCR Signaling with Dr. Michelle Halls | Dr. GPCR Ecosystem
in Molecular Pharmacology at Monash University, then trained in single-cell biology as an NHMRC CJ Martin
- Brian Arey: Discovering Signaling Bias at the FSH Receptor | Dr. GPCR Ecosystem
biased signaling is evolutionarily conserved, and why he chose a book over a review 48:09 Dinner with Martin "I'm not surprised." - Martin Rodbell, upon being shown Arey's FSH signaling data drawn on a dinner napkin
- Xylazine, Fentanyl, and the Fight for Breath with Catherine Demery | Dr. GPCR Ecosystem
gripping conversation, Catherine, a PhD candidate at the University of Michigan, shares how personal loss How loss and lived experience can sharpen scientific focus. But loss has a way of sharpening focus—friends lost to overdose brought the opioid epidemic into painful
- Silvio Gutkind: When GPCRs Drive Cancer | Dr. GPCR Ecosystem
the most drugged protein family in medicine, but until recently their role in cancer was treated as marginal In knockout mice, loss of CXCR3 abolishes response to both anti-PD-1 and anti-CTLA-4, reframing the receptor
- Terms and Conditions | Dr. GPCR Ecosystem
Ecosystem.DrGPCR.com shall not be responsible or liable, directly or indirectly, for any damage or loss the third party, and the Customer agrees that Ecosystem.DrGPCR.com shall not be held liable for any loss is not liable, and Customer agrees not to hold Ecosystem.DrGPCR.com responsible, for any damages or losses (including, but not limited to, loss of money, goodwill or reputation, profits, or other intangible attorneys, advertisers, product and service providers, and affiliates harmless from any liability, loss
- Masha Niv: Bitter Taste Receptors and the Drug Discovery Blind Spot | Dr. GPCR Ecosystem
science - how a global consortium formed from a handful of tweets and what it found about taste and smell loss COVID-19 taste loss was a scientific detour that became something larger Niv had not planned to work and found that while both smell and taste are impaired in the majority of symptomatic cases, smell loss unexpected result - heavy water activates the T1R2/T1R3 heterodimer 23:53 - COVID-19 and chemosensory loss
- Dr. Ralf Jockers | Dr. GPCR Ecosystem
He discovered multiple rare and loss-of-function variants of the MT2 melatonin receptors that are associated
- Beatriz Blanco-Redondo: Adhesion GPCR Discovery in Drosophila | Dr. GPCR Ecosystem
it tractable: new lines in weeks, knockouts in months, and behavioral readouts that connect receptor loss to human vascular and neurological pathology In the peripheral nervous system of Drosophila larvae, loss
- Dr. John Streicher: Reorganizing Opioid Signaling Beyond the Receptor | Dr. GPCR Ecosystem
look at what it means to modulate opioid pharmacology downstream of the receptor — and why the safety margins
- Chris Tate: Thermostabilizing GPCRs for Structural Biology | Dr. GPCR Ecosystem
chemically possible Thermostabilizing the beta-adrenergic receptor by 21 degrees Celsius was not a marginal
- Silvio Gutkind: Building a Lab That Doesn't Shut Down | Dr. GPCR Ecosystem
Gutkind — carrying a personal loss in New York and leading a cancer center building that operated at
- Paul Insel: Rethinking COVID-19 Pathobiology Through GPCR Signaling | Dr. GPCR Ecosystem
a disease of signaling imbalance: an overdrive of AT1R activation by angiotensin II, paired with a loss
- Terry Hebert: How Cellular Background and Localization Influence GPCR Function | Dr. GPCR Ecosystem
knockout cell is intrinsically different from the wild-type — complicating any conclusions drawn from loss-of-function
- Michel Bouvier: BRET, Biased Agonism, and the Tools That Changed GPCR Pharmacology | Dr. GPCR Ecosystem
This conversation covers the arc of that career: the personal loss that drew Bouvier toward the sympathetic The proximity assay that resulted, inspired by marine bioluminescence, became one of the most widely why Bouvier has never had a favorite receptor 20:03 The origin of BRET - dimerization controversy, marine
- Tore Bengtsson: Rethinking β₂-Adrenergic Signaling in Metabolic Disease | Dr. GPCR Ecosystem
Have a Fundamental Limitation Traditional β₂-adrenergic agonists can stimulate muscle growth and fat loss























